Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

December Catalysts

- Start of cohort 10 (possible dosage increase)
- Start of B-OM (phase 2)
- Start of K + Cytarabine (phase 1b/2)
- FDA meetings on B-ABSSSI & P
- Release of B-ABSSSI bottom line data

2015 Q1 Catalysts

- Biotech Showcase (Jan. 12-14)
- Start of B-ABSSSI (phase 3)
- Start of P (phase 2/3)
- Completion of K (phase 1)
- Formulations of B-Ocular, B-Otic, diabetic foot infections

Milestones

- Completion of cohort 9 (350 mg/m2)
- B-ABSSSI phase 2b positive top-line data
- P phase 1 primary endpoint met
- Formulation of B stable at room temperature

Stock Performances

- 1M: -$0.15 (-4.52%)
- 3M: +$1.12 (+54.63%)
- 6M: +$1.48 (+87.57%)
- 1Y: +$1.54 (+94.48%)

I will try to update this list every month. If I miss something, please let me know.